Sorrento Therapeutics, Inc. - Nov 23, 2022 Form 4 Insider Report for Scilex Holding Company/DE (SCLX)

Role
10%+ Owner
Signature
/s/ Henry Ji, Ph.D., President, Chief Executive Officer and Chairman of the Board, Sorrento Therapeutics, Inc.
Stock symbol
SCLX
Transactions as of
Nov 23, 2022
Transactions value $
$175,670
Form type
4
Date filed
11/23/2022, 04:59 PM
Previous filing
Nov 22, 2022
Next filing
Nov 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCLX Warrants to Purchase Common Stock Purchase $176K +443K +11.73% $0.40 4.22M Nov 23, 2022 Common Stock 443K $11.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2444 to $0.45 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price.